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Abstract 
Sudden hearing loss is a sensorineural hypoacusis, unilateral in most of the cases, with an incidence peak in 
young adult. This article is the result of a four years retrospective study, in which we have tried to see how age, severity 
of hearing loss, presence or absence of vertigo, the timing of treatment initiation can influence the hearing recovery. 
47 patients were included in this inpatient study. They were investigated (clinical, lab and imaging studies) and 
the treatment protocol included vasodilators, anti-inflammatory agents, vitamins, plasma expander. 
In conclusion, a good prognosis in the hearing recovery was associated with absence of vertigo, early treatment 
(the first 7 days), and hearing loss less than 50dB. Age had no influence upon the recovery process. 
 
Introduction 
 
Sudden hearing loss (SHL) is a sudden decrease or loss of hearing defined on audiometric 
criteria  based  on  severity  and  time  course.  A  commonly  used  criterion  for  diagnosis  is  a 
sensorineural hypoacusis of greater than 30dB over 3 contiguous audiometric frequencies. It was 
first described in the literature by De Klevn in 1944. 
Female-to-male  distribution  appears  to  be  almost  equal.  People  of  all  age  groups  are 
affected, with a peak incidence between 30-60 years. Fortunately, the majority of cases of SHL are 
unilateral. Bilateral hearing loss occurs in approximately 1-2% of cases. 
The epidemiology for sudden hearing loss has four theoretical pathways: a viral infection, a 
vascular compromise, an intracochlear membrane rupture (theory favored by Simmons in 1968 [1] 
and Goodhill in 1979 [2]) and immune-mediated inner ear disease (first described by McCabe in 
1979 [3]). 
The auditory system is complex and it depends on the normal function of the middle ear, 
cochlea and the central nervous system. Also, the hearing can be influenced by the metabolic, 
vascular, and endocrine systems. Any damage of one of these systems can affect the inner ear. So, 
sudden hearing loss can have many possible etiologies: 
-  infection (bacterial: meningitis, Scarlet fever; viral: mumps, varicella, cytomegalovirus); 
-  inflammation (sarcoidosis, Wegener granulomatosis, Cogan syndrome); 
-  vascular  (hypercoagulable  states,  thrombosis  or  embolism  of  the  internal  audit  artery, 
hypertension); 
-  tumor (acoustic neuroma, metastasis); 
-  trauma (temporal bone fracture, acoustic trauma); 
-  toxins (amino glycoside, cisplatin); 
-  endocrine abnormalities (hypothyroidism).  
The  symptoms  appear  sudden.  Most  patients  report  a  hearing  loss  within  minutes to  several 
hours. The firs and most common symptom is deafness. It can be accompanied by tinnitus (80%), 
vertigo, headache, queasiness. 
Even  if  the  diagnosis  of  sudden  hearing  loss  is  easy  at  a  first  glance,  in  reality  it  is  more 
complicated especially in those cases when other otic disorders coexist or when the patient can’t say 
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Material and methods 
 
A 4 years retrospective study through which we wanted to see how age, severity of hearing 
loss, presence or absence of vertigo, the timing of the initiation of treatment can influence the 
hearing recovery. 
47 patients were included in this inpatient study. We underlined the characteristics related to 
patient’s age, gender, associated pathology, the symptoms, the timing of treatment and the hearing 
recovery. 
People of all age groups were affected, with a peak between 50-70 years. (Fig 1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gender repartition was: 49% female and 51% males. 
Almost  all  patients  presented  as  a  first  symptom  sudden  hypoacusis.  Fortunately,  the 
majority  of  cases  were  unilateral  (left  ear  53,19%,  right  ear  38,3%)  (see  Fig  2).  Patients  also 
presented tinnitus, vertigo (8 cases), headache and queasiness. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
It is said that there is a connection between vascular risk factors and the ones who can give a 
sudden deafness [4]. Hypercholesterolemia, smoking, cardiovascular pathology are risk factors for a 
sudden hearing loss. Pathologic anamnesis revealed that 28 patients had such a risk. 
In the primary evaluation and the diagnosis each patient made a tonal audiogram, which we 
have  repeated  during  and  after  the  treatment,  as  a  final  evaluation,  so  we  could  evaluate  the 
treatment efficiency and the hearing recovery. (see Fig 3). 
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Depending on patients’ symptoms and associated pathology, we have done some tests like: 
acoustic evoked potentials, echo Doppler and brain CT or MRI (in those cases in which the auditory 
tests were pathologic). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
We  used  a  ten  days  treatment  with  vasodilators  (Pentoxifylline  200mg  per  day),  anti-
inflammatory agents (Cortisone 300-400mg per day), vitamins (B1, B6, and Calcium), and plasma 
expander 500mg per day. In 5 cases we also administrated antiviral agents and in 2 cases heparin. 
Eustachian tube permeabilisation maneuvers were used in 5 patients. Due to the economic reasons 
we could not use the hyperbaric oxygen therapy. 
 
Results and discussions 
 
Patients’ evolution under treatment was different. Complete recovery of hearing was found 
in 20 cases (42,55%). 18 patients (38,3%) had a 10-40dB recovery on the tonal audiogram but 
without reaching the normal standards, and 9 patients with severe hypoacusis had no recovery. 
Analysis of recovery rates according to specific measurements of the severity of hearing 
loss,  revealed a  significant  difference  in favor  of  those  with  less  severe  deafness.  Unster et  al 
reported  that  prognosis  for  recovery  was  very  poor  in  patients  whose  hearing  loss  was  total. 
Shiraishi [5] also reported a complete, moderate, or slight recovery in 38% patients with a severe 
hearing loss. Our findings were consistent with those in the literature. No recovery in 9 patients 
with severe hypoacusis. 
Our study revealed that a hearing loss of more than 50-60dB on audiogram, even with a 
good treatment, presented a moderate recovery no greater than 20-30dB. Greater the hearing loss, 
the worse is the recovery prognosis, because it reveals an irreversible lesion. 
Hearing recovery is also influenced by the timing of the treatment initiation [5]. Earlier 
treatment (the first 7 days) was associated with a better prognosis, even a complete recovery. 
The presence of vertigo was a negative prognosis factor. Moskowitz et al [6] reported that 
the presence of vertigo indicates a poor prognosis; they found that only 14% of patients they studied 
achieved a complete recovery of hearing. In our study, 8 patients were vertigo-positive, and none of 
them presented a good recovery. 
Vertigo  shows  a  damage  of  the  vestibulocochlear  pathways.  For  a  good  diagnosis  an 
electronystagmography or an electrocochleography can be made. If we think that the mechanism 
could  be a  vascular  one, an  angio-MRI  could  be  useful.  The  auditory  evoked  potentials,  brain 
response time-locked to some “event” in this case a sound, are also very important. Otoacoustic 
emissions tests can also be used in the diagnosis of SHL, their primary purpose being to determinate 
cochlear status. 
Chart 3 - Hypoacusis severity
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The  hearing  recovery  in  patients  with  a  cardiovascular  pathology,  a  stroke  in  their 
antecedents or a hypertension peak, was modest. 
Recovery was independent of age.  
The  treatment  regimens  of  SHL  are  varied  and  this  diversity  reflects  both  the  different 
etiologies and the uncertainty in diagnosis. The protocol, which we also used in our department, 
included vasodilators, anti-inflammatory agents, vitamins, plasma expander, antiviral agents and 
heparin. 
Theoretically,  vasodilators  improve  the  blood  supply  to  the  cochlea,  reversing  hypoxia. 
There are studies made on the real effect of Pentoxifylline and Ginkgo biloba, but none of them 
have provided its benefit versus placebo. Certain studies showed that βhistine reduces the cochlear 
hypoxia and improves the hearing [7]. 
The use of Dextran (plasma expander) has also been suggested as a means of creating a 
hypervolemic hemodilution, this causing a decrease in blood viscosity and an increase in cochlear 
blood flow [8]. 
Hypoxia goes to an inflammatory reaction with a release of histamine, eicosanoids, and 
prostaglandins. Corticosteroids are the primary anti-inflammatory agents used to treat SHL. The 
mechanism of action of cortisone is reduction of cochlear and auditory nerve inflammation [6,9]. In 
a recent study [10], intratympanic injection of Dexamethasone is shown to effectively improve 
hearing in patients with severe sudden hearing loss after treatment failure with standard therapy 
(Ho, 2005)[11]. 
After six days of treatment patients were evaluated with a tonal audiogram. If there was no 
change in their hearing features the treatment was stopped. Also, if there was a hearing recovery we 
administrated Ginkgo biloba and βhistine. 
The treatment after the acute faze of the disease, at those patients with risks, consisted from 
Magnesium, recent studies showing that it may be good in preventing the SHL. Also, the role of 
antioxidants  in  sudden  hearing  loss  prevention  was  explained  by  reducing  lipidic-peroxidase 
synthesis[7,9]. 
In  addition  to  all  these  therapies,  another  effective  treatment  for  sudden  hypoacusis  is 
hyperbaric oxygen therapy. It was first introduced by the Marseille School of otology [13]. A recent 
study showed that an exposure to 100% oxygen at a pressure of 250kPa for 60 minutes improves 
the  results  of  conventional  treatment  (Narozny,  2004)[14].  The  best  results  are  achieved  if  the 
treatment is started as soon as possible.  
 
Conclusions 
 
-  in our study most of the causes of the sudden hearing loss were of vascular origin; 
-  the presence of vertigo is a negative prognostic factor; 
-  the  sooner  the  treatment  with  vasodilators  and  corticosteroids  begins,  the  higher  are  the 
recovery rates; 
-  almost 70% of our cases had a good evolution under treatment; 
-  performing tests for vestibulocochlear system, auditory evoked potentials and MRI (if the 
above tests are pathologic) to exclude other pathologies; 
-  the patient reevaluation is necessary after 6 months. 
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